• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤稿：利伐沙班联合替格瑞洛在非瓣膜性心房颤动合并急性冠状动脉综合征患者PCI术后抗栓治疗中的价值

Retracted: The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome.

作者信息

And Alternative Medicine Evidence-Based Complementary

出版信息

Evid Based Complement Alternat Med. 2023 Jul 19;2023:9769353. doi: 10.1155/2023/9769353. eCollection 2023.

DOI:10.1155/2023/9769353
PMID:37501878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10371514/
Abstract

[This retracts the article DOI: 10.1155/2022/4807175.].

摘要

[本文撤回文章DOI: 10.1155/2022/4807175。]

相似文献

1
Retracted: The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome.撤稿：利伐沙班联合替格瑞洛在非瓣膜性心房颤动合并急性冠状动脉综合征患者PCI术后抗栓治疗中的价值
Evid Based Complement Alternat Med. 2023 Jul 19;2023:9769353. doi: 10.1155/2023/9769353. eCollection 2023.
2
The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome.利伐沙班联合替格瑞洛在非瓣膜性心房颤动合并急性冠状动脉综合征患者PCI术后抗栓治疗中的价值
Evid Based Complement Alternat Med. 2022 Nov 3;2022:4807175. doi: 10.1155/2022/4807175. eCollection 2022.
3
Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention.利伐沙班和替格瑞洛在接受经皮冠状动脉介入治疗的老年房颤患者中的疗效和安全性。
Contemp Clin Trials. 2021 May;104:106365. doi: 10.1016/j.cct.2021.106365. Epub 2021 Mar 18.
4
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.RT-AF研究的原理与设计：利伐沙班与替格瑞洛联合用于接受经皮冠状动脉介入治疗的心房颤动合并冠状动脉疾病患者
Contemp Clin Trials. 2015 Jul;43:129-32. doi: 10.1016/j.cct.2015.05.012. Epub 2015 May 21.
5
Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.伴有心房颤动和植入新一代药物洗脱支架的急性冠状动脉综合征患者的最佳抗血栓治疗的理由和设计：新型抗血栓药物（OPTIMA）-4 试验。
Clin Cardiol. 2023 Jul;46(7):777-784. doi: 10.1002/clc.24025. Epub 2023 May 16.
6
Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study.中国非瓣膜性心房颤动合并急性冠状动脉综合征或接受经皮冠状动脉介入治疗患者的抗栓治疗模式演变：一项横断面研究
Front Cardiovasc Med. 2022 Mar 18;9:846803. doi: 10.3389/fcvm.2022.846803. eCollection 2022.
7
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.经皮冠状动脉介入治疗（PCI）后伴有心房颤动患者的口服抗凝药物转换：RE-DUAL PCI 试验亚组分析。
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2331-2341. doi: 10.1016/j.jcin.2019.08.039.
8
Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.经皮冠状动脉介入治疗的心房颤动患者抗栓治疗趋势：来自希腊抗血小板心房颤动（GRAPE-AF）登记研究的见解。
Cardiovasc Drugs Ther. 2021 Feb;35(1):11-20. doi: 10.1007/s10557-020-07090-x. Epub 2020 Oct 9.
9
Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients.中国患者 PCI 术后利伐沙班联合氯吡格雷抗栓治疗的安全性和有效性评价。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221074681. doi: 10.1177/10760296221074681.
10
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes.达比加群双重治疗与华法林三联治疗用于伴有糖尿病的房颤患者经皮冠状动脉介入术后
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2346-2355. doi: 10.1016/j.jcin.2019.07.059.

本文引用的文献

1
The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome.利伐沙班联合替格瑞洛在非瓣膜性心房颤动合并急性冠状动脉综合征患者PCI术后抗栓治疗中的价值
Evid Based Complement Alternat Med. 2022 Nov 3;2022:4807175. doi: 10.1155/2022/4807175. eCollection 2022.